Proof is a company.
Proof has raised $175.0M across 4 funding rounds.
Key people at Proof.
Proof has raised $175.0M in total across 4 funding rounds.
PROOF is the Pro Rata Opportunity Fund, an expansion-stage venture capital firm that invests strategic capital alongside select early-stage VC firms to help them maintain pro-rata ownership in their top-performing portfolio companies[1][4][6]. This preserves VCs' board influence, cap table positions, and returns as companies scale, addressing the common issue where broad portfolios deplete capital for follow-on rounds[1]. With over $700M in assets under management since its 2015 inception, PROOF targets hypergrowth category leaders across sectors like biotech (e.g., Colossal Biosciences), logistics (Zipline), healthtech (Rula Health), fintech (DailyPay), and construction tech (ICON)[4]. Its model amplifies upside in the startup ecosystem by enabling sustained VC involvement in winners, fostering deeper operational support and faster scaling for high-potential ventures[1][4].
Founded in 2015, PROOF emerged to solve a structural gap in venture investing: early-stage VCs often exhaust pro-rata rights in breakout companies due to diversified portfolios[1][4]. Key partners leverage networks from top firms, partnering selectively to co-invest in proven winners without competing in initial rounds[1]. The firm has evolved from a niche pro-rata specialist to an expansion-stage player with a portfolio emphasizing global hypergrowth leaders, growing AUM to over $700M while maintaining a focused strategy of backing category-defining companies[4].
PROOF rides the wave of venture capital maturation, where power-law returns concentrate in a tiny fraction of startups, making pro-rata preservation critical amid lengthening timelines to exit[1][4]. Timing aligns with a post-2022 funding reset, where disciplined follow-on capital differentiates winners in a capital-constrained environment[4]. Market forces like rising interest rates and selective LP allocations favor specialists like PROOF, which unlock upside without primary risk. It influences the ecosystem by stabilizing top VC portfolios, encouraging bolder early bets and reducing churn in breakout companies' cap tables[1].
PROOF is poised to expand its $700M+ AUM by deepening ties with emerging VC powerhouses in AI, climate, and health, capitalizing on a rebound in late-stage funding[4]. Trends like AI-driven efficiencies and on-demand capital will amplify demand for its model, potentially evolving into full secondary solutions for VC liquidity. As portfolios consolidate around fewer winners, PROOF's niche will grow influential, maximizing upside where early VCs need it most—cementing its role in fueling the next wave of category leaders[1][4].
Key people at Proof.
Proof has raised $175.0M in total across 4 funding rounds.
Proof's investors include Camber Creek, CapitalG, Citi Ventures, 2xN, Coelius Capital, Crosslink Capital, Eclipse Ventures, Golden Ventures, IA Capital Group, Lemnos Labs, MS&AD Ventures, Pareto Holdings.
Proof has raised $175.0M across 4 funding rounds. Most recently, it raised $130.0M Series D in March 2021.
